Company profile
Aurora Cannabis Inc.
NASDAQ: ACB · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Edmonton, ABCIK 0001683541Reports USD
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 71
v0.1 · 5/100 weight · pillars only
↑ workforce scale, return on assets · ↓ filing timeliness, Altman-Z
Methodology →Revenue TTM
$224.6M
Rev growth YoY (TTM)
-8.9%
Net income (FY)
$1.1M
Employees
1,028
as of 2026-08-14
Market cap
$234.8M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income$1.1M1.6M CAD2025
Total assets$593.1M852.7M CAD2025
Liabilities$169.8M244.1M CAD2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Aurora Cannabis Inc.’s financial profile?
Aurora Cannabis Inc. earned $1.1M in FY2025 net income.
Peers · Healthcare
Anavex Life Sciences Corp.——Turn Therapeutics Inc.——Alamar Biosciences, Inc.——Greenwich LifeSciences, Inc.——Immunic, Inc.——AN2 Therapeutics, Inc.——Key facts
CEOMiguel Martin
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersEdmonton, AB
ExchangeNASDAQ: ACB
Employees1,028
IPO date2014-07-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.